Mobile-health Network Solutions ['MaNaDr'](NASDAQ:MNDR), a leading Asia-Pacific telehealth provider, today announced updated pricing for its medical weight management program, improving the affordability and accessibility of GLP-1 (glucagon-like peptide-1) receptor agonist medications?in the Asia-Pacific (APAC) region.
Save time and jump to the most important pieces.
SINGAPORE, Oct. 21, 2024 (GLOBE NEWSWIRE) -- Mobile-health Network Solutions (NASDAQ:MNDR) ("MaNaDr" or "the Company"), a leading Asia-Pacific telehealth provider, today announced that it would host a conference call on Thursday, October 24th, 2024, at 8:00 AM ET to discuss the company's Fiscal Year 2024 financial results ended June 30th, 2024. These results will be announced on Wednesday, October 23rd, shortly after 4:00 PM ET. To participate in the conference call, please dial 1-800-445-7795 or 1-203-518-9783 approximately 5 to 10 minutes before the beginning of the call, using the Conference ID "MNDR." The Company will be answering questions live on the conference call, and inve
20-F/A - Mobile-health Network Solutions (0001976695) (Filer)
20-F - Mobile-health Network Solutions (0001976695) (Filer)
6-K - Mobile-health Network Solutions (0001976695) (Filer)
SINGAPORE, Oct. 23, 2024 (GLOBE NEWSWIRE) -- Mobile-health Network Solutions (NASDAQ:MNDR) ("MaNaDr" or "the Company"), a leading Asia-Pacific telehealth provider, today announced that for the fiscal year 2024 ended June 30, 2024, the Company had revenue of $14.0 million, a $6.1 million, or 77 percent, improvement on revenue of $7.9 million for fiscal 2023. This improvement was due to increased revenue of $6.0 million contributed by the Company's telemedicine and other services segment, and $0.1 million by MNDR's sale of medicine and medical devices segment. Cost of revenue increased by $4.7 million, or 69 percent, in fiscal 2024, mainly due to a 70 percent increase in the number of
SINGAPORE, Oct. 21, 2024 (GLOBE NEWSWIRE) -- Mobile-health Network Solutions (NASDAQ:MNDR) ("MaNaDr" or "the Company"), a leading Asia-Pacific telehealth provider, today announced that it would host a conference call on Thursday, October 24th, 2024, at 8:00 AM ET to discuss the company's Fiscal Year 2024 financial results ended June 30th, 2024. These results will be announced on Wednesday, October 23rd, shortly after 4:00 PM ET. To participate in the conference call, please dial 1-800-445-7795 or 1-203-518-9783 approximately 5 to 10 minutes before the beginning of the call, using the Conference ID "MNDR." The Company will be answering questions live on the conference call, and inve
SINGAPORE, Sept. 27, 2024 (GLOBE NEWSWIRE) -- Mobile-health Network Solutions (NASDAQ:MNDR) ("MaNaDr" or "the Company"), a leading Asia-Pacific telehealth provider, today announced that the Company will attend and present at the following financial conferences: Lytham Partners Fall 2024 Investor Conference Conference Date: Tuesday, October 1, 2024Conference Location: Virtual Company Presentation: October 1, 2024, at 3:30-4:00 PM ET To watch the Company Presentation virtually, please go here or contact Lytham Partners at [email protected] to register for the event and schedule a meeting with our company. Additionally, we will conduct a fireside chat moderated by Barry Sine, Equity
Gainers Tempest Therapeutics (NASDAQ:TPST) shares rose 32.8% to $3.79 during Thursday's pre-market session. The company's market cap stands at $84.0 million. Neurogene (NASDAQ:NGNE) shares rose 31.92% to $40.0. The company's market cap stands at $519.2 million. Geovax Labs (NASDAQ:GOVX) shares rose 28.94% to $2.45. The company's market cap stands at $6.1 million. SAB Biotherapeutics (NASDAQ:SABS) stock moved upwards by 24.03% to $3.2. The market value of their outstanding shares is at $29.5 million. Trevena (NASDAQ:TRVN) stock rose 23.33% to $0.44. The market value of their outstanding shares is at $8.0 million. Molecular Partners (NASDAQ:MOLN) stock rose 22.23% to $9.73. The company's